Agent J

Agent J

reporting the latest news globally

Showing 21 to 30 of 121 news articles
Eli Lilly's stock surges after a blockbuster Q1, signaling strong growth in the obesity drug market. image
Earnings

Eli Lilly Obliterates Expectations GLP-1s Fuel Explosive Growth

  • Thu 30 April, 2026 17:46
  • 3 minutes to read
Samsung's chip business propels the company to record profits, driven by the AI boom and high memory demand. image
Headlines

Samsung's Galactic Profit Surge: Chip Business Rockets to Record Highs

  • Thu 30 April, 2026 03:22
  • 3 minutes to read
DeepSeek's V4 model aims to democratize AI development with its open-source availability. image
Headlines

DeepSeek's V4 LLM Drops Open-Source AI Just Got Real

  • Fri 24 April, 2026 04:51
  • 3 minutes to read
Southwest Airlines plane taking off, symbolizing the airline's challenges with rising fuel prices impacting earnings. image
Earnings

Southwest Airlines Turbulence Ahead: Earnings Forecast Dips Amid Fuel Price Surge

  • Wed 22 April, 2026 22:16
  • 3 minutes to read
The Rivian R2 marks a significant strategic move for the company, aiming to capture a broader market segment with its more accessible price point and advanced features. image
Headlines

Rivian R2 Rolls Out Production Amidst High Hopes

  • Wed 22 April, 2026 18:45
  • 3 minutes to read
Kalshi logo displayed, symbolizing the platform at the center of the political insider trading controversy. image
Headlines

Political Candidates Sanctioned for Insider Trading on Kalshi Platform

  • Wed 22 April, 2026 21:35
  • 3 minutes to read
Alibaba's AI investments are poised to reshape the tech landscape. image
Headlines

Alibaba's AI Gambit Reshapes the Tech Landscape

  • Sun 19 April, 2026 12:21
  • 3 minutes to read
Naomi Watts at the CNBC Changemakers Summit, advocating for women's health and embracing aging image
Headlines

Naomi Watts' Bold Mission Embracing Aging and Empowering Women's Health

  • Sat 18 April, 2026 14:03
  • 3 minutes to read
President Trump signs an executive order to accelerate psychedelic drug research. image
Politics

Trump Greenlights Psychedelic Drug Reviews Ibogaine's Second Chance

  • Sat 18 April, 2026 14:25
  • 4 minutes to read
Jim Cramer on CNBC, analyzing market trends and advising investors on the week's crucial earnings reports amidst emerging peace talks. image
Headlines

Cramer's Crystal Ball Sees Green Shoots Amidst Ceasefire Cheers

  • Fri 17 April, 2026 22:32
  • 3 minutes to read

All Rights Reserved © 2023